PARTELLI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 542
EU - Europa 217
AS - Asia 86
AF - Africa 14
SA - Sud America 1
Totale 860
Nazione #
US - Stati Uniti d'America 542
UA - Ucraina 44
IT - Italia 43
SG - Singapore 35
IE - Irlanda 34
SE - Svezia 30
CN - Cina 23
DE - Germania 21
DK - Danimarca 15
TR - Turchia 12
FR - Francia 9
FI - Finlandia 8
KR - Corea 8
MA - Marocco 8
CI - Costa d'Avorio 6
GB - Regno Unito 5
BE - Belgio 4
JP - Giappone 3
IN - India 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BR - Brasile 1
BY - Bielorussia 1
EE - Estonia 1
IL - Israele 1
NL - Olanda 1
VN - Vietnam 1
Totale 860
Città #
Chandler 61
Fairfield 61
Jacksonville 55
Ashburn 49
Des Moines 36
Dublin 34
Boardman 25
Wilmington 25
Woodbridge 22
Houston 21
Singapore 19
New York 17
Seattle 17
Cambridge 12
Lawrence 12
Princeton 12
San Mateo 12
Ann Arbor 10
Abidjan 6
Centro 6
Marche 5
Brussels 4
Helsinki 4
San Diego 4
Turin 4
Dallas 3
Guangzhou 3
London 3
Porto 3
Rome 3
Shanghai 3
Washington 3
Beijing 2
Los Angeles 2
Milan 2
Norwalk 2
Pune 2
Cupra Marittima 1
Dubai 1
Hadera 1
Hounslow 1
Jiaxing 1
Jiujiang 1
Kilburn 1
Minsk 1
Mondolfo 1
Ningbo 1
Paris 1
Qingdao 1
Redwood City 1
Shenzhen 1
Taiyuan 1
Tallinn 1
Tirana 1
Wuhan 1
Totale 582
Nome #
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 85
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 83
Impact of postoperative complications on long-term survival after resection of pancreatic ductal adenocarcinoma 80
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 80
Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms 73
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 73
Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms 72
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 69
Enhanced recovery pathways in pancreatic surgery: State of the art 68
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 67
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 61
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology 55
Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 14
Totale 880
Categoria #
all - tutte 5.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.353


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 0 10 0 10 1 3 11
2020/2021207 19 15 27 0 13 12 16 9 27 23 37 9
2021/202288 1 24 7 1 1 5 5 7 10 2 11 14
2022/2023230 17 30 12 16 12 53 0 11 51 1 21 6
2023/2024126 26 3 17 12 17 32 2 6 0 1 0 10
2024/202587 24 24 7 2 16 14 0 0 0 0 0 0
Totale 880